Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
about
Why not treat human cancer with interleukin-1 blockade?Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesAutoinflammation: translating mechanism to therapy.Therapy of autoinflammatory syndromes.Molecular mechanisms in genetically defined autoinflammatory diseases: disorders of amplified danger signaling.Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007Biological treatments: new weapons in the management of monogenic autoinflammatory disordersFrom the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases.Monogenic autoinflammatory diseases: concept and clinical manifestations.The Central Role of Anti-IL-1 Blockade in the Treatment of Monogenic and Multi-Factorial Autoinflammatory Diseases.Monogenic autoinflammatory diseases: disorders of amplified danger sensing and cytokine dysregulation.The plodding diagnosis of monogenic autoinflammatory diseases in childhood: from the clinical scenery to laboratory investigation.The NLRP3 inflammasome in health and disease: the good, the bad and the ugly.Current advances in the understanding and treatment of mevalonate kinase deficiency.Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience.Anakinra and related drugs targeting interleukin-1 in the treatment of cryopyrin-associated periodic syndromes.Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.Anti-interleukin-1 treatment in 26 patients with refractory familial mediterranean fever.[Autoinflammatory syndromes/fever syndromes].Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.Anti-interleukin 6 receptor therapy for hyper-IgD syndrome.The promising potential role of ketones in inflammatory dermatologic disease: a new frontier in treatment research.
P2860
Q33833871-016B7DDF-71DB-4A9D-9221-F8982B6C11F2Q35133812-9438A49C-0EA4-4690-ACBA-72CFA5BABAE8Q35558406-B990F372-48B4-4CEA-A5D8-EC1DDBE1678DQ35868028-520490AC-56F1-49CF-98D6-27D083B74BFAQ36041225-55CA6D08-ED2D-4B5E-92F8-158E56B53CDDQ36171750-577CF7FA-1383-4BD1-B5B4-A9D11601AAB5Q37077564-5522FBE8-FA63-40F9-8947-769BA99ED4C6Q37077793-E189FA26-399F-4018-9CC8-D0E48E6FBEF1Q37162157-B7BADFDB-C783-4747-AB98-355653F5252DQ37270409-F6682FFE-DC6B-4D32-997A-CD2BCA779D8AQ37466515-ECD3B81A-8A4D-423F-9F05-7D689AD66E53Q37833103-C946A75A-89EE-4F94-8A91-973A7F1C6C72Q37901519-78229DEB-AD88-4ED0-8FE9-9981B3E15001Q38311990-85DA3E06-6547-45CF-8013-61016125B904Q38365710-2514EC8F-A6C5-409D-89D0-EFFDCC3F31A8Q38993312-881502E9-C8BA-4601-8EC5-A72124481214Q40057989-46981C3C-C5AD-4D07-988E-269774B2CC9BQ40100395-3D38867E-F54E-40D5-9B79-7B249021E46FQ40326095-A6D0D9BA-0468-4380-AC52-24635161CA52Q40371224-CFC0CB1E-B350-4979-8BD2-EE95F8F685ECQ43184639-08A66E62-E28E-4A8B-AE0D-5115F2265A56Q46437947-7464F046-F65F-480C-8BEE-D2E84C2659BD
P2860
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@ast
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@en
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@nl
type
label
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@ast
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@en
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@nl
prefLabel
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@ast
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@en
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@nl
P2093
P1476
Treatment with anakinra in the hyperimmunoglobulinemia D/periodic fever syndrome.
@en
P2093
Achille Stabile
Anna Lisa Pugliese
Barbara Bertoni
Donato Rigante
Gilda Federico
Laura Avallone
Valentina Ansuini
P2860
P2888
P304
P356
10.1007/S00296-006-0164-X
P577
2006-07-27T00:00:00Z
P6179
1035353093